Literature DB >> 18427595

Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Jerry A Shields1, Carol L Shields, Arman Mashayekhi, Brian P Marr, Raquel Benavides, Archana Thangappan, Laura Phan, Ralph C Eagle.   

Abstract

PURPOSE: To evaluate clinical features and risks for transformation of conjunctival primary acquired melanosis (PAM) into melanoma.
METHODS: Retrospective chart review and Kaplan-Meier estimates of times to PAM enlargement, recurrence, and transformation into melanoma. MAIN OUTCOME MEASURES: PAM enlargement, recurrence, and transformation into melanoma.
RESULTS: The mean patient age at diagnosis of PAM was 56 years; 62% were female and 96% Caucasian. The conjunctival quadrant(s) affected by PAM and its extent in clock hours were recorded. Initial management included observation in 62%, biopsy combined with cryotherapy in 34%, and other methods in 4%. Of PAM that was observed, Kaplan-Meier estimates at 10 years revealed PAM enlargement in 35% and transformation into melanoma in 12%. Of those that underwent incisional or excisional biopsy, 10-year estimates of PAM recurrence and transformation into melanoma were 58% and 11%, respectively. Progression to melanoma occurred in 0% of PAM without atypia, 0% of PAM with mild atypia, and 13% of PAM with severe atypia. Multivariable analysis revealed that the most significant factor for both PAM recurrence and progression to melanoma was extent of PAM in clock hours.
CONCLUSION: PAM without atypia or with mild atypia shows 0% progression into melanoma, whereas PAM with severe atypia shows progression into melanoma in 13%. The greater the extent of PAM in clock hours, the greater the risk for transformation into melanoma.

Entities:  

Mesh:

Year:  2007        PMID: 18427595      PMCID: PMC2258121     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  30 in total

1.  Correspondence re: A. B. Ackerman, R. Sood, and M. Koenig, Primary acquired melanosis of the conjunctiva is melanoma in situ. Mod Pathol 4:253, 1991.

Authors:  H E Grossniklaus
Journal:  Mod Pathol       Date:  1992-07       Impact factor: 7.842

2.  Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento.

Authors:  A D Paridaens; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

3.  Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.

Authors:  J Frucht-Pery; J Pe'er
Journal:  Arch Ophthalmol       Date:  1996-10

4.  Clinical characterization of primary acquired melanosis.

Authors:  P Gloor; G Alexandrakis
Journal:  Gaz Med Fr       Date:  1995-07

Review 5.  Primary acquired melanosis of the conjunctiva is melanoma in situ.

Authors:  A B Ackerman; R Sood; M Koenig
Journal:  Mod Pathol       Date:  1991-03       Impact factor: 7.842

6.  Malignant melanomas of the conjunctiva, nasal cavity, and paranasal sinuses.

Authors:  D M Robertson; J L Hungerford; A McCartney
Journal:  Am J Ophthalmol       Date:  1989-10-15       Impact factor: 5.258

7.  Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.

Authors:  C L Shields; J A Shields; K Gündüz; J Cater; G V Mercado; N Gross; B Lally
Journal:  Arch Ophthalmol       Date:  2000-11

Review 8.  Conjunctival lesions in adults. A clinical and histopathologic review.

Authors:  H E Grossniklaus; W R Green; M Luckenbach; C C Chan
Journal:  Cornea       Date:  1987       Impact factor: 2.651

9.  Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases.

Authors:  F A Jakobiec; F J Rini; F T Fraunfelder; S Brownstein
Journal:  Ophthalmology       Date:  1988-08       Impact factor: 12.079

Review 10.  Benign conjunctival melanocytic lesions. Clinicopathologic features.

Authors:  R Folberg; F A Jakobiec; V B Bernardino; T Iwamoto
Journal:  Ophthalmology       Date:  1989-04       Impact factor: 12.079

View more
  16 in total

1.  Primary Acquired Melanosis: Clinical, Histopathologic and Optical Coherence Tomographic Correlation.

Authors:  Yahya A Alzahrani; Smita Kumar; Hassan Abdul Aziz; Thomas Plesec; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2015-11-12

2.  Sinonasal melanoma arising from conjunctival primary acquired melanosis.

Authors:  Mark Shehata; Dan Gombos; John Bishop; Mark Edwin Zafereo
Journal:  BMJ Case Rep       Date:  2015-02-18

3.  Management of conjunctival malignant melanoma: a review and update.

Authors:  James R Wong; Afshan A Nanji; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2014-06

4.  Population-based incidence of conjunctival tumours in Olmsted County, Minnesota.

Authors:  Lauren A Dalvin; Diva R Salomão; Sanjay V Patel
Journal:  Br J Ophthalmol       Date:  2018-03-06       Impact factor: 4.638

Review 5.  Mucosal melanomas: a case-based review of the literature.

Authors:  Nagashree Seetharamu; Patrick A Ott; Anna C Pavlick
Journal:  Oncologist       Date:  2010-06-22

6.  Unilateral Conjunctival in situ Squamous Carcinoma with Bilateral Conjunctival Chlorpromazine-Induced Secondary Melanosis Masquerading as in situ and Invasive Melanoma.

Authors:  Katharine S Sears; Ian G Rennie; Hardeep Singh Mudhar
Journal:  Ocul Oncol Pathol       Date:  2015-04-01

Review 7.  Ocular melanoma: an overview of the current status.

Authors:  Predrag Jovanovic; Marija Mihajlovic; Jasmina Djordjevic-Jocic; Slobodan Vlajkovic; Sonja Cekic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

8.  Pigmented Conjunctival Lesions as Presenting Signs of Vaginal Melanoma.

Authors:  Paul O Phelps; Martha J Farber; Dale R Meyer
Journal:  Ocul Oncol Pathol       Date:  2017-08-23

9.  Clinical profile of melanocytic lesions of the ocular surface in a Hispanic population.

Authors:  Lucas A Garza-Garza; Eugenia M Ramos-Davila; Raul E Ruiz-Lozano; Kathia Gutierrez-Juarez; Julio C Hernandez-Camarena
Journal:  Int Ophthalmol       Date:  2022-04-19       Impact factor: 2.029

Review 10.  Conjunctival melanoma and melanocytic intra-epithelial neoplasia.

Authors:  N Kenawy; S L Lake; S E Coupland; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.